Package 85006-1754-1

Brand: alymsys

Generic: bevacizumab-maly
NDC Package

Package Facts

Identity

Package NDC 85006-1754-1
Digits Only 8500617541
Product NDC 85006-1754
Product ID 85006-1754_57bed0ca-700b-448c-a429-5aafea7b4ce9
Description

1 VIAL in 1 CARTON (85006-1754-1) / 4 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2022-04-15
Brand alymsys
Generic bevacizumab-maly
Sample Package No

Linked Drug Pages (1)

ALYMSYS ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "57bed0ca-700b-448c-a429-5aafea7b4ce9", "openfda": {"upc": ["0385006175519", "0385006175410"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2599043", "2599049", "2599051", "2599052"], "spl_set_id": ["42b4f96e-1f70-2126-e063-6294a90a93e3"], "manufacturer_name": ["Valorum Biologics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (85006-1754-1)  / 4 mL in 1 VIAL", "package_ndc": "85006-1754-1", "marketing_start_date": "20220415"}], "brand_name": "ALYMSYS", "product_id": "85006-1754_57bed0ca-700b-448c-a429-5aafea7b4ce9", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "85006-1754", "generic_name": "bevacizumab-maly", "labeler_name": "Valorum Biologics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ALYMSYS", "active_ingredients": [{"name": "BEVACIZUMAB-MALY", "strength": "100 mg/4mL"}], "application_number": "BLA761231", "marketing_category": "BLA", "marketing_start_date": "20220415", "listing_expiration_date": "20271231"}